BRIEF-BridgeBio Pharma Q4 Net Income USD -267.389 Million Vs. IBES Estimate USD -201.3 Million

Reuters
20 Feb
BRIEF-BridgeBio Pharma Q4 Net Income USD -267.389 Million Vs. IBES Estimate USD -201.3 Million

Feb 20 (Reuters) - BridgeBio Pharma Q4 revenue USD 5.882 million vs. IBES estimate USD 3.48 million.

  • Q4 basic EPS USD -1.4
  • Q4 operating income USD -226.027 million vs. IBES estimate USD -191.4 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10